Original Article

Genetic Counseling, Screening and Risk-Reducing Surgery in Patients with Primary Breast Cancer and Germline BRCA Mutations: Unmet Needs in Low- and Middle-Income Countries
  • Hiba A. Moukadem
  • Ahmad Al Masry
  • Rula W. Atwani
  • Firas Kreidieh
  • Lana E. Khalil
  • Rita Saroufim
  • Sarah Daouk
  • Iman Abou Dalle
  • Nagi S. El Saghir
Eur J Breast Health 2022; 18: 16-20 DOI: 10.4274/ejbh.galenos.2021.2021-5-1 PMID:35059587
Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study
  • Muhammed Mustafa Atcı
  • Çağlayan Geredeli
  • Seval Ay
  • Abdullah Sakin
  • Biray Ertürk
  • Şaban Seçmeler
  • Serdar Arıcı
  • Ruhper Çekin
  • Nurgül Yaşar
  • Orçun Can
  • Şener Cihan
  • Mahmut Gümüş
Eur J Breast Health 2021; 17: 123-127 DOI: 10.4274/ejbh.galenos.2020.6346 PMID:33870111
Oncological Safety of Lipofilling in Healthy BRCA Carriers After Bilateral Prophylactic Mastectomy: A Case Series
  • Christophe Ho Quoc
  • Leonardo Pires Novais Dias
  • Oddone Freitas Melro Braghiroli
  • Nunzia Martella
  • Vincenzo Giovinazzo
  • Jean-Marc Piat
Eur J Breast Health 2019; 15: 217-221 DOI: 10.5152/ejbh.2019.5013
Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients
  • İzzet Doğan
  • Esra Aydın
  • Hülya Yazıcı
  • Pınar Saip
Eur J Breast Health 2022; 18: 323-328 DOI: 10.4274/ejbh.galenos.2022.2022-5-2 PMID:36248747

Letter to the Editor

What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers
  • Gianluca Franceschini
  • Riccardo Masetti
Eur J Breast Health 2019; 15: 135-136 DOI: 10.5152/ejbh.2019.4651